---
figid: PMC5346332__nihms844224f1
figlink: /pmc/articles/PMC5346332/figure/F1/
number: F1
caption: 'Constitutive low levels of IFN-β that are produced by most cell types “prime”
  type I IFNs producing cells for a robust type I IFNs production upon sensing “danger”
  signals such as cytosolic DNA and TLR ligands. Left panel: The “priming” involves
  (i) binding of the IFN-β to a cell surface type I IFN receptor; (ii) activation
  of the Jak-STAT pathway; (iii) formation of the ISGF3 transcription factor that
  includes the STAT1, STAT2 and IRF9 proteins in the cytoplasm and translocation of
  ISGF3 ternary protein complex to the nucleus; and (iv) binding of the nuclear ISGF3
  transcription factor to interferon-stimulated response element(s) (ISREs) that are
  present in type I IFN-stimulated genes (ISGs). These genes include IRF7 and STAT1.
  The binding activates transcription of the IRF7 and STAT1 genes, resulting in increased
  levels of IRF7 and STAT1 proteins. Right panel: Increased levels of IRF7 and STAT1
  proteins in “primed” cells potentiate an increased production of type I IFNs and
  the expression of ISGs such as cGAS and STING in response to sensing cytosolic DNA
  by cGAS, a cytosolic DNA sensor. cGAS activates the STING-TBK1-IRF3 pathway to induce
  the expression of IFN-β. Similarly, toll-like receptor (TLR) ligands activate a
  signaling pathway that activates the IRF3 and IRF7. The IRF3 and IRF7 heterodimer
  induces the expression of IFN-β and IFN-α genes. Thus, “primed” cells produce higher
  levels of type I IFNs and activate a robust type I IFN response (express higher
  levels of ISGs).'
pmcid: PMC5346332
papertitle: Absent in Melanoma 2 proteins in SLE.
reftext: Divaker Choubey, et al. Clin Immunol. ;176:42-48.
pmc_ranked_result_index: '45399'
pathway_score: 0.9032701
filename: nihms844224f1.jpg
figtitle: Constitutive low levels of IFNB that are produced by most cell types “prime”
  type I IFNs producing cells for a robust type I IFNs production upon sensing “danger”
  signals such as cytosolic DNA and TLR ligands
year: ''
organisms:
- Mus musculus
- Francisella tularensis
- Homo sapiens
- Bos taurus
ndex: ce6a3c74-debf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5346332__nihms844224f1.html
  '@type': Dataset
  description: 'Constitutive low levels of IFN-β that are produced by most cell types
    “prime” type I IFNs producing cells for a robust type I IFNs production upon sensing
    “danger” signals such as cytosolic DNA and TLR ligands. Left panel: The “priming”
    involves (i) binding of the IFN-β to a cell surface type I IFN receptor; (ii)
    activation of the Jak-STAT pathway; (iii) formation of the ISGF3 transcription
    factor that includes the STAT1, STAT2 and IRF9 proteins in the cytoplasm and translocation
    of ISGF3 ternary protein complex to the nucleus; and (iv) binding of the nuclear
    ISGF3 transcription factor to interferon-stimulated response element(s) (ISREs)
    that are present in type I IFN-stimulated genes (ISGs). These genes include IRF7
    and STAT1. The binding activates transcription of the IRF7 and STAT1 genes, resulting
    in increased levels of IRF7 and STAT1 proteins. Right panel: Increased levels
    of IRF7 and STAT1 proteins in “primed” cells potentiate an increased production
    of type I IFNs and the expression of ISGs such as cGAS and STING in response to
    sensing cytosolic DNA by cGAS, a cytosolic DNA sensor. cGAS activates the STING-TBK1-IRF3
    pathway to induce the expression of IFN-β. Similarly, toll-like receptor (TLR)
    ligands activate a signaling pathway that activates the IRF3 and IRF7. The IRF3
    and IRF7 heterodimer induces the expression of IFN-β and IFN-α genes. Thus, “primed”
    cells produce higher levels of type I IFNs and activate a robust type I IFN response
    (express higher levels of ISGs).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA10
  - IRF9
  - IFNA17
  - STAT2
  - STAT1
  - IFNB1
  - IFNA14
  - IFNA16
  - IFNA4
  - IFNA21
  - IRF3
  - IRF7
  - TMEM173
  - IFNAR2
  - CGAS
  - IFNA2
  - IFNAR1
  - IFNA1
  - IFNA13
  - IFNA5
  - TYK2
  - IFNA8
  - TBK1
  - IFNA7
  - IFNA6
genes:
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: Stat2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: ISGF3
  symbol: ISGF-3
  source: hgnc_alias_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFN-B.
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: STING
  symbol: STING
  source: hgnc_alias_symbol
  hgnc_symbol: TMEM173
  entrez: '340061'
- word: Stat1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: CGAS
  symbol: CGAS
  source: hgnc_symbol
  hgnc_symbol: CGAS
  entrez: '115004'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IFN-a
  symbol: IFN-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: Tyk2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IFNB,IFNA,CGAS,STING
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
chemicals: []
diseases: []
figid_alias: PMC5346332__F1
redirect_from: /figures/PMC5346332__F1
figtype: Figure
---
